Introduction
Angiopoietins are a family of growth factors which act on the Tie receptor on endothelial cells. The angiopoietin family consists of 4 angiopoietins, i.e., angiopoietin-1 (Ang1), angiopoietin-2 (Ang2), angiopoietin-3 (Ang3), and angiopoietin-4 (Ang4) [1] [2] [3] . Ang1 is known as an angiogenic factor 4) , however, the function of Ang2, Ang3 and Ang4 is not well known. Angiopoietins' receptor system consists of two receptor tyrosine kinases, Tie1 and Tie2.
The Tie receptors are exclusively expressed by endothelial cells and hematopoietic cells 5) . It has been also reported that Tie2 is also expressed in macrophages, eosinophils, and hematopoietic stem cells 5, 6) . Although Tie1 and Tie2
share a similar structure consisting of an extracellular domain with 33% similarity and an intracellular tyrosine kinase domain with 76% similarity, the exact role of Tie1
is not well known 7) . Ang1 and Ang2 bind to the same site in Tie2 with similar affinities. Ang1 is a widely Key Words : angiopoietin-1; kidney; endothelial cells is expressed on endothelial cells, and it regulates vascular growth, development, maturation, and permeability 8, 9) .
Ang1-induced Tie2 phosphorylation in endothelial cells
can activate the protein kinase B/Akt pathway that conducts endothelial survival [10] [11] [12] . Although Ang1 is known as an angiogenic factor, it has been also demonstrated that
Ang1 has an anti-inflammatory effect 13, 14) . Although the exact role of Ang2 is not well known, it has been reported that Ang2 functions as an antagonist ligand of Tie2 15) .
Ang1 has potential therapeutic applications in inducing angiogenesis, enhancing endothelial cells survival, and preventing vascular leakage 12, [16] [17] [18] [19] [20] (Fig. 1) .
In this section, I focus on the therapeutic effect of Ang1 in kidney disease
Angiopoietin-1 and Tie2 expression in kidney
Ang1 is also associated with physiologic or pathophysiologic conditions in the kidney 21) . In kidney development, Tie2 is detected in capillaries of the nephrogenic cortex, glomerular tufts, cortical interstitium, and medulla including vessels in the vasa recta 22, 23) . Thus, Ang1 and Tie2 play roles in the maturation of glomeruli and the vasa rectae. Ang1 protein is detected in podocytes in normal glomeruli and was highly expressed in podocyte foot processes 24) . Tie2 has been demonstrated on glomerular capillary endothelial cells and peritubular capillary endothelial cells 23) . Thus, circulating Ang1 may have an effect on renal Tie2 in the endothelial cell and renal Ang1 may also have paracrine effect on renal Tie2 25, 26) .
Disturbance 
Cartilage oligomeric matrix protein-angiopoietin-1 in renal fibrosis
Most forms of chronic kidney disease finally progress to interstitial fibrosis. The severity of tubulointerstitial changes is the best indicator of the progression of renal dysfunction 29, 30) . Renal tubulointerstitial fibrosis is an important feature in unilateral ureteral obstruction (UUO).
In humans, chronic and acute ureteral obstruction can occur in various clinical situations such as ureteral stone or ureteral carcinoma. Injury to the renal microvasculature and inflammatory condition may be major factors in the process of kidney disease 31) . In particular, injury to the peritubular capillary endothelium of the kidney may be a factor in tubulointerstitial disease [32] [33] [34] . It has been reported that impaired angiogenesis may occur in the diseased kidney and can contribute to renal scarring 33) . Renal ische- 
Conclusion
The protective effect of COMP-Ang1 on of the renal endothelial cell and regulation of inflammatory process may be an important therapeutic target of renal disease.
Therefore, COMP-Ang1 may be an endothelium-specific therapeutic modality in various renal diseases.
